328 related articles for article (PubMed ID: 34228987)
1. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.
Zhou Y; Wang M; Li Y; Wang P; Zhao P; Yang Z; Wang S; Zhang L; Li Z; Jia K; Zhong C; Li N; Yu Y; Hou J
Immunol Lett; 2021 Sep; 237():33-41. PubMed ID: 34228987
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.
Zhang Y; Gargan S; Roche FM; Frieman M; Stevenson NJ
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458397
[TBL] [Abstract][Full Text] [Related]
3. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells.
Thuy PX; Bao TDD; Moon EY
Biomed Pharmacother; 2022 Jun; 150():113021. PubMed ID: 35658221
[TBL] [Abstract][Full Text] [Related]
5. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
Fuentes-Prior P
J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
[TBL] [Abstract][Full Text] [Related]
6. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
7. Escherichia coli infection activates the production of IFN-α and IFN-β via the JAK1/STAT1/2 signaling pathway in lung cells.
Jin Y; Jia Z; Cai Q; Sun Y; Liu Z
Amino Acids; 2021 Oct; 53(10):1609-1622. PubMed ID: 34524541
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
9. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
Ge J; Zhang S; Zhang L; Wang X
Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
Verma D; Church TM; Swaminathan S
J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy.
Chen J; Li S; Lei Z; Tang Q; Mo L; Zhao X; Xie F; Zi D; Tan J
Int J Biol Sci; 2021; 17(11):2957-2969. PubMed ID: 34345219
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 spike D614G change enhances replication and transmission.
Zhou B; Thao TTN; Hoffmann D; Taddeo A; Ebert N; Labroussaa F; Pohlmann A; King J; Steiner S; Kelly JN; Portmann J; Halwe NJ; Ulrich L; Trüeb BS; Fan X; Hoffmann B; Wang L; Thomann L; Lin X; Stalder H; Pozzi B; de Brot S; Jiang N; Cui D; Hossain J; Wilson MM; Keller MW; Stark TJ; Barnes JR; Dijkman R; Jores J; Benarafa C; Wentworth DE; Thiel V; Beer M
Nature; 2021 Apr; 592(7852):122-127. PubMed ID: 33636719
[TBL] [Abstract][Full Text] [Related]
15. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
Guney C; Akar F
J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315
[TBL] [Abstract][Full Text] [Related]
16. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.
Khaddaj-Mallat R; Aldib N; Bernard M; Paquette AS; Ferreira A; Lecordier S; Saghatelyan A; Flamand L; ElAli A
Neurobiol Dis; 2021 Dec; 161():105561. PubMed ID: 34780863
[TBL] [Abstract][Full Text] [Related]
18. Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein.
Heinzelman P; Romero PA
PLoS One; 2021; 16(5):e0251585. PubMed ID: 33979391
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
[TBL] [Abstract][Full Text] [Related]
20. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
